NanoVibronix Files 8-K for Regulation FD Disclosure
Ticker: FEED · Form: 8-K · Filed: Nov 19, 2025 · CIK: 1326706
| Field | Detail |
|---|---|
| Company | Nanovibronix, Inc. (FEED) |
| Form Type | 8-K |
| Filed Date | Nov 19, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: NVBX
TL;DR
NVBX filed an 8-K for a Reg FD disclosure on 11/19/25. Details TBD.
AI Summary
NanoVibronix, Inc. filed an 8-K on November 19, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or details about the nature of the disclosure, only that it pertains to Regulation FD.
Why It Matters
This filing indicates NanoVibronix is making a public disclosure under Regulation FD, which ensures fair disclosure of material information to all investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without immediate financial impact or significant new information.
Key Players & Entities
- NanoVibronix, Inc. (company) — Registrant
- November 19, 2025 (date) — Date of Report
- Regulation FD (regulation) — Disclosure Type
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the content of the Regulation FD disclosure, only that one is being made.
When was this 8-K filing submitted?
The 8-K filing was submitted on November 19, 2025.
What is the primary purpose of this 8-K filing?
The primary purpose is to report a Regulation FD Disclosure.
What is NanoVibronix, Inc.'s principal executive office address?
The principal executive offices are located at 969 Pruitt Ave, Tyler, Texas 77569.
What is the Commission File Number for NanoVibronix, Inc.?
The Commission File Number is 001-36445.
Filing Stats: 502 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2025-11-19 08:00:39
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share NAOV Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 36KB
- 0001493152-25-024167.txt ( ) — 240KB
- naov-20251119.xsd (EX-101.SCH) — 3KB
- naov-20251119_lab.xml (EX-101.LAB) — 33KB
- naov-20251119_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NanoVibronix, Inc. Date: November 19, 2025 By: /s/ Doron Besser, M.D. Name: Doron Besser, M.D. Title: Chief Executive Officer